Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Immunol.

Sec. Inflammation

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1634014

Novel Diagnostic Biomarkers Associated with Macrophage-Microglia in Spinal Cord Injury

Provisionally accepted
Manyi  ZhengManyi Zheng1Yunduo  JiangYunduo Jiang1Fangyu  LiuFangyu Liu1Yansong  WangYansong Wang1,2,3*
  • 1The First Affiliated Hospital of Harbin Medical University,Harbin Medical University, Heilongjiang, China
  • 2The Key Laboratory of Myocardial Ischemia, Ministry of Education, Harbin Medical University, Harbin, China
  • 3NHC Key Laboratory of Cell Transplantation, Harbin Medical University, Harbin, China

The final, formatted version of the article will be published soon.

Background Spinal cord injury (SCI) is a devastating disorder featuring serious motor dysfunction and proprioceptive deficits due to central nervous system (CNS) damage. During its progression, macrophage-microglia (MM) cells are rapidly activated and play pivotal roles in the inflammatory response through various mechanisms. However, limited research has investigated the differential gene expression between the two groups before and after injury, and these important genes may therefore serve as potential biological diagnostic markers. Methods Our study utilized the Gene Expression Omnibus (GEO) data for SCI-related MDEG identification. Key hub genes were screened using multiple machine learning(ML) algorithms. Their predictive potential was subsequently validated using independent datasets, and their association with immune cell infiltration was assessed. An in vitro model of SCI was established, and quantitative polymerase chain reaction (qPCR) experiments were conducted to verify our findings. Results Single-cell RNA sequencing identified 16 distinct cellular subpopulations, among which MM cells were split into four subsets according to functional characteristics. Enrichment analyses, including KEGG, GO, and GSEA, revealed that the MDEGs were closely linked to key biological processes in SCI. From 200 genes associated with critical WGCNA modules, three hub genes, including EMP3, GNGT2, and SGPL1, were identified through four ML algorithms as differentially expressed before and after injury. Predictive models based on these genes demonstrated strong performance in both internal training and external validation cohorts. Preliminary analysis of immune infiltration and gene-immune cell correlation suggests an association with M2 macrophages. Furthermore, in vitro modeling of post-injury inflammation confirmed the elevated expression of EMP3, GNGT2, and SGPL1. Conclusion Our study identifies EMP3, GNGT2, and SGPL1 as potential diagnostic biomarkers associated with MM cells in SCI. The foregoing findings lay a theoretical basis for elucidating their biological roles and formulating future treatment strategies.

Keywords: spinal cord injury, single-cell RNA sequencing, Bulk RNA sequencing, Microglia, macrophage, Inflammation, immune microenvironment

Received: 23 May 2025; Accepted: 26 Aug 2025.

Copyright: © 2025 Zheng, Jiang, Liu and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Yansong Wang, The First Affiliated Hospital of Harbin Medical University,Harbin Medical University, Heilongjiang, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.